Swiss Trauma Registry

February 17, 2025 updated by: University Hospital, Basel, Switzerland

Observational Retrospective and Prospective Registry With Standardized Data Collection on Trauma Treatment in Switzerland

The Swiss Conference of Cantonal Health Directors has transferred the planning of highly specialized medicine to a specialized body under the direction of the Swiss Academy of Sciences. This specialist body has defined the treatment of critically ill as part of highly specialized medicine and founded the Swiss Trauma Registry at 12 hospitals in Switzerland. The registry is designed to provide a consistent and standardized approach and treatment outcomes in the short and long term quality control and as a basis for planning highly specialized medicine.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Switzerland
      • Aarau, Switzerland, 5001
      • Basel, Switzerland, 4031
        • Recruiting
        • University Hospital Switzerland, Traumatology
        • Contact:
      • Bern, Switzerland, 3010
      • Chur, Switzerland, 7000
      • Geneva, Switzerland, 1211
      • Lausanne, Switzerland, 1011
      • Lugano, Switzerland, 6900
      • Luzern, Switzerland, 6000
      • ST. Gallen, Switzerland, 9007
      • Sion, Switzerland, 1951
      • Winterthur, Switzerland, 8401
      • Zürich, Switzerland, 8091

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

severely injured patients at hospitals

Description

Inclusion Criteria:

  • injury severity code > 16 and 7 or abbreviated injury scale >3 for region of skull and brain

Exclusion Criteria:

  • patients who will transferred in a burn unit
  • drowned patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality in severely injured patients
Time Frame: day of injury until year 5
number of severely injured patients who died
day of injury until year 5
patterns of injuries in severely injured patients
Time Frame: day of injury until year 5
comparison of patterns of injuries in severely injured patients
day of injury until year 5
Duration of primary hospitalisation after initial injury measured by days
Time Frame: day of injury until year 5
Duration of primary hospitalisation after initial injury measured by days
day of injury until year 5
Duration of secondary hospitalisation after initial injury measured by days
Time Frame: day of injury until year 5
Duration of secondary hospitalisation after initial injury measured by days
day of injury until year 5
Treatment costs in Swiss Francs
Time Frame: day of injury until year 5
Treatment costs in Swiss Francs
day of injury until year 5
line of treatments due to the initial injury (kind of treatment)
Time Frame: day of injury until year 5
line of treatments due to the initial injury (kind of treatment)
day of injury until year 5
line of treatments due to the initial injury (timepoints of treatments)
Time Frame: day of injury until year 5
line of treatments due to the initial injury (timepoints of treatments)
day of injury until year 5
Duration of Rehabilitation measured by days
Time Frame: day of injury until year 5
Duration of Rehabilitation measured by days
day of injury until year 5
Duration of incapacity for work measured by days
Time Frame: day of injury until year 5
Duration of incapacity for work measured by days
day of injury until year 5
diagnostic efforts measured by number and timepoint of imaging
Time Frame: day of injury until year 5
number and timepoint of imaging
day of injury until year 5
treatment efforts measured by number of medication given
Time Frame: day of injury until year 5
number and timepoint of medication given and medical interventions performed
day of injury until year 5
Primary supply Dates measured in minutes
Time Frame: on day of primary hospitalisation
Primary supply Dates measured by time to start of surgery, time to admission to trauma room, time to ICU admission
on day of primary hospitalisation
treatment efforts measured by number of medical interventions performed
Time Frame: day of injury until year 5
Treatment efforts measured by number and timepoint of medication given and medical interventions performed
day of injury until year 5
treatment efforts measured by timepoint of medication given
Time Frame: day of injury until year 5
Treatment efforts measured by number and timepoint of medication given and medical interventions performed
day of injury until year 5
treatment efforts measured by timepoint of medical interventions performed
Time Frame: day of injury until year 5
Treatment efforts measured by number and timepoint of medication given and medical interventions performed
day of injury until year 5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Basel, Switzerland

Investigators

  • Principal Investigator: Andreas Marc Müller, Prof MD, University Hospital, Basel, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Estimated)

December 31, 2040

Study Completion (Estimated)

December 31, 2040

Study Registration Dates

First Submitted

March 19, 2018

First Submitted That Met QC Criteria

May 15, 2018

First Posted (Actual)

May 16, 2018

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 17, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013-00331; ch18Jakob2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe